Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Food Ingredients Chin... Food Ingredients China
Not Confirmed
Not Confirmed
17-19 March, 2026
RNA Leaders EuropeRNA Leaders Europe
Not Confirmed
Not Confirmed
17-19 March, 2026
Rare Disease SummitRare Disease Summit
Not Confirmed
Not Confirmed
17-19 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Food Ingredients Chin... Food Ingredients China
Industry Trade Show
Not Confirmed
17-19 March, 2026
RNA Leaders EuropeRNA Leaders Europe
Industry Trade Show
Not Confirmed
17-19 March, 2026
Rare Disease SummitRare Disease Summit
Industry Trade Show
Not Confirmed
17-19 March, 2026
Digital content

05 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/05/3021042/0/en/Algernon-NeuroScience-Appoints-Validcare-as-CRO-for-its-Phase-2a-DMT-Human-Stroke-Trial-and-Announces-Validcare-s-USD-170K-Equity-Investment.html
ABOUT THIS PAGE